Biochemical Pharmacology, 65 (3): 397-405 Publisher Elsevier Item record/more information http://hdl.handle.net/10197/5862 Publisher's statement þÿ T h i s i s t h e a u t h o r s v e r s i o n o f a w o r k t h a t Abstract Endothelium-dependent vasodilation is thought to be mediated primarily by the NO/cGMP signalling pathway whereas cAMP-elevating vasodilators are considered to act independent of the endothelial cell layer. However, recent functional data suggest that cAMP-elevating vasodilators such as β-receptor agonists, adenosine or forskolin may also be endothelium-dependent. Here we used functional and biochemical assays to analyze endothelium-dependent, cGMP-and cAMP-mediated signalling in rat aorta. Acetylcholine and sodium nitroprusside (SNP) induced a concentration-dependent relaxation of phenylephrine precontracted aorta. This response was reflected by the phosphorylation of the vasodilator-stimulated phosphoprotein (VASP), a validated substrate of cGMP-and cAMP-dependent protein kinases (cGK, cAK), on Ser 157 and Ser 239 . As expected, the effects of acetylcholine were endothelium-dependent. However, relaxation induced by the β-receptor agonist isoproterenol was also almost completely impaired after endothelial denudation. At the biochemical level, acetylcholine-and isoproterenol-evoked cGK and cAK activation, respectively, as measured by VASP Ser 239 and
Introduction
Vascular tone can be regulated by a variety of vasoconstricting and vasodilating agents. Two major vasodilator pathways utilize the cyclic nucleotides cAMP and cGMP as messenger molecules. The cAMP pathway is initiated by receptor-mediated stimulation of adenylyl cyclase and leads to the activation of cAMP-dependent protein kinase (cAK). cGMP, which is synthesized in the smooth muscle cell layer following the activation of soluble guanylyl cyclase by endothelium-derived nitric oxide (NO), regulates ion-channels, phosphodiesterases and cGMP-dependent protein kinases (cGK) [1] . Type I cGK has been shown to mediate the vasodilatory action of NO in mouse aorta [2] , at least at low concentrations of NO [3] . A validated substrate of cGK I as well as cAK is the vasodilator-stimulated phosphoprotein (VASP), a protein localized at actin filaments, focal adhesions and dynamic membrane regions [4] . Other described substrates of cGK I in smooth muscle are the cytoskeletal proteins RhoA [5] and the myosin binding subunit of myosin phosphatase [6] . cGK I also regulates the release of calcium from intracellular stores, e.g. via the IP 3 -receptor-interacting protein IRAG [7] . Usually the NO/cGMP pathway is considered to be endothelium-dependent, whereas cAMP-elevating pathways are not. Recently however, a number of reports have challenged this concept suggesting that cAMP-elevating agents such as βadrenoreceptor agonists and adenosine have an endothelium-dependent component to the vasorelaxant response [8] [9] [10] [11] [12] . One possible mechanism involved could be the activation of eNOS and endothelial NO formation by cAMP [12, 13] . A promising new tool for the analysis of cAMP-and cGMP-dependent pathways is the phosphorylation state of the cAK and cGK I substrate VASP. VASP phosphorylation has been shown to be a marker of the activity of the NO/cGMP pathway in a number of studies of animal models of endothelial function and dysfunction [14] [15] [16] [17] [18] as well as in humans [19] . These studies were performed using an antibody against the phosphorylation site Ser 239 of VASP. This antibody was generated by us initially to study cGK I function in platelets [20] . VASP contains two additional cGK phosphorylation sites, namely Ser 157 and Thr 278 , although the latter is phosphorylated with low efficiency [21] . In general the VASP Ser 157 and Ser 239 sites are phosphorylated by both cAK as well as cGK I, although studies with human platelets and endothelial cells suggested a preference of cGK I for the Ser 239 site whereas cAK phosphorylates Ser 157 faster [20, 22] .
In the present study we determined the extent of endothelium-dependence of cAMP-mediated vasodilation of rat aorta in comparison with the cGMP pathway. In order to gain more information on the mechanisms involved we compared direct activation of adenylyl cyclase using forskolin with indirect receptormediated activation of the cAMP pathway using isoproterenol. In addition to vasodilation as common endpoint of the signalling pathways the kinase activity of cAK and cGK was measured directly using VASP Ser 157 and Ser 239 phosphorylation.
Materials and Methods

Vascular reactivity studies
Male Wistar rats (200-250 g) were purchased from Charles River and anaesthetized with 60 mg/ kg pentobarbital administered intraperitoneally. The chest was opened and the descending thoracic aorta was dissected, cleaned of connective tissue and cut into 3 mm rings which were mounted in an organ bath (FMI) for isometric force measurements. In some rings endothelium was removed by gentle rubbing of the intimal surface with a stainless steel forceps and only rings with contractile responses to KCl and phenylephrine comparable to endotheliumintact rings were included in the analysis of relaxant responses and VASP phosphorylation. The rings were equilibrated for 30 minutes under a resting tension of 2 g in oxygenated (95% O 2 ; 5% CO 2 ) Krebs-Henseleit solution (NaCl 118 mmol/L, KCl 4.7 mmol/L, MgSO 4 1.2 mmol/L, CaCl 2 1.6 mmol/L, K 2 HPO 4 1.2 mmol/L, NaHCO 3 25 mmol/L, glucose 12 mmol/L; pH 7.4, 37°C) containing diclofenac (1 µmol/L) [23] . Rings were repeatedly contracted by KCl (with a maximum of 100 mmol/L) until reproducible responses were obtained.
Presence or absence of functional endothelium was confirmed using acetylcholine (1 mmol/L). After 60 minutes of resting at baseline tension following repeated washouts rings were precontracted with phenylephrine (0.3-1 µmol/L) to comparable constriction levels and the relaxant responses to single doses of the different vasodilators were assessed.
After achievement of stabile relaxant responses the rings were rapidly dismounted and immediately frozen in liquid nitrogen. Afterwards samples were stored at -80°C until western blot analysis was performed. 
Western Blot analysis
Antibodies
The following primary antibodies were used: rabbit anti-cGK I (1:5000, [24] ), mouse anti-α-actinin (1:1000, Sigma), rabbit anti-total-VASP (M4, 1:3000, [25] ), mouse anti-phospho-Ser 239 -VASP (16C2, 2µg/ml, [20] ) and mouse anti-phospho-Ser 157 -VASP (5C6, 4 µg/ml, [20, 22, 26] ). The secondary antibodies were: Cye 5.5 antimouse (1:5000) and IRDye800 anti-rabbit (1:5000), both from LI-COR.
Substances
Phenylephrine, acetylcholine, sodiumnitroprusside (SNP), forskolin, isoproterenol, N G -nitro-L-arginine and diclofenac were purchased from Sigma.
Statistics
Statistical analysis was performed by a 2-way ANOVA followed by a Bonferroni t test, with probability values of <0.05 considered statistically significant.
Results
Measurement of VASP phosphorylation in rat aorta
We studied the activity of cAMP-and cGMP-regulated protein kinases by measuring the phosphorylation state of their substrate VASP. VASP content and phosphorylation state were studied in Western Blots using antibodies against native VASP ( Figure 1B ) and phosphospecific antibodies against the phosphorylation sites Ser 239 and Ser 157 . The phospho-Ser 157 antibody is a newly developed antibody which was tested in this study for the first time on vascular tissue samples. In rat aorta this antibody detected a single band of 50 kDa ( Figure 1C ).
To control for total protein loading the amount of α-actinin was determined on the same blot. In addition cGK I expression was measured ( Figure 1A ). The total amount of cGK I detectable by Western blot was not changed after removal of the endothelium, however about 20 % of total VASP was lost. In the presence of endothelium a basal phosphorylation of VASP Ser 157 and Ser 239 could be detected ( [14] and data not shown). After endothelial denudation the P-Ser 157 and P-Ser 239 signals were reduced by 40 % and 85 %, respectively ( Figure 2 ). Thus the P-Ser 239 signal showed the most pronounced endothelium-dependence.
Effects of acetylcholine and SNP on aortic relaxation and VASP phosphorylation
In phenylephrine-precontracted aortic rings, single doses of acetylcholine induced a concentration-dependent relaxation ( Figure 3A ). As expected this response was completely blunted after removal of the endothelium. As shown in Figure 3B Figure 4A ). The phosphorylation of VASP reflected the rise in vasodilator-activity: the phospho-VASP to VASP ratio reached a maximum of 0.7 at the highest concentration of SNP used ( Figure   4B ). Moreover VASP phosphorylation was independent of the presence or absence of endothelium ( Figure 4B ).
The intensity of the phospho-VASP signal induced by SNP was similar on both serines studied. cGK I expression was not changed under all conditions tested (data not shown).
Effects of forskolin and isoproterenol on aortic relaxation and VASP phosphorylation
We next treated phenylephrine-precontracted aortic rings with cAMP-elevating vasodilators. Forskolin generated a partially endothelium-dependent vasodilatory response: the extent of vascular relaxation was reduced in the absence of endothelium only at the lower concentrations of forskolin (10, 100 nmol/L) used, the maximal relaxation at 1 µM/L forskolin was not changed ( Figure 5A ). Interestingly the forskolin-induced VASP phosphorylation on Ser 239 was strongly reduced after endothelial denudation but VASP Ser 157 phosphorylation remained almost unchanged ( Figure 5B ).
In contrast isoproterenol elicited a very striking endothelium-dependent vasodilation ( Figure 6A ). This effect was mirrored in the VASP phosphorylation state: after removal of the endothelium only a very weak phospho-VASP signal could be detected with either of the phospho-specific antibodies ( Figure 6B ). Interestingly at low isoproterenol concentrations in the presence of endothelium the phosphorylation of the Ser 239 site appeared much stronger compared to the Ser 157 phosphorylation. cGK I expression was not changed under the conditions tested (data not shown).
To analyze the role of NO formation for the observed endothelium dependent effects of isoproterenol we preincubated aortic rings with the NOS inhibitor N G -nitro-L-arginine (100 µmol/L for 45 min) in the absence of diclofenac. In parallel to endothelium-denuded segments, the isoproterenol induced vasodilation was strongly diminished: only one fourth of the relaxation was achieved with 1 µM isoproterenol in the presence of N G -nitro-L-arginine as compared to control (data not shown). The phospho-Ser 239 to total VASP ratio was reduced to 0.15 in the presence of N G -nitro-L-arginine as compared to 0.5 with isoproterenol alone (data not shown).
Discussion
The most important finding of the present study is the pronounced endothelium-dependence of cAMP-elevating vasodilators. Especially isoproterenol-induced vasodilation and cyclic nucleotide regulated kinase activation were almost completely blocked after endothelial denudation. In this respect isoproterenol effects were very similar to the classic endothelium-dependent vasodilator acetylcholine. Furthermore the effect of the direct adenylyl cyclase activator forskolin was at least partially endothelium-dependent. Interestingly forskolin-induced VASP Ser 239 phosphorylation was completely blocked after removal of the endothelium indicating a loss of cGK I activity. Our functional data are supported by previous studies [8, 10, 11] . Very recently, Zhang and Hintze [12] reported an increase in nitrite formation in dog coronary microvessels after administration of similar concentrations of isoproterenol and forskolin as used in our study. However, in contrast to this study and our results with isoproterenol, we observed only partially endothelium-dependent effects of forskolin in rat aorta.
The differences in extent of cAMP-mediated crossactivation of the NO/cGMP pathway might be explained by species and vessel type differences. One basic mechanism involved in the crosstalk probably is an activation of endothelial NO synthase (eNOS) by the cAMP pathway. eNOS is known as a Ca 2+ /calmodulin (CaM) dependent protein which can be activated by Ca 2+ mobilizing agents such as acetylcholine or bradykinin. The activation has been suggested to involve a dephosphorylation of eNOS at Thr 495 and phosphorylation at Ser 1179 [27] [28] [29] . Ser 1179 of eNOS can be phosphorylated by multiple protein kinases, including AMP-activated protein kinase [30] , PKB (serine/threonine protein kinase Akt [31, 32] ) and also cAK [13] . Boo et al. recently suggested eNOS Ser 1179 phosphorylation by cAK to be responsible for shear stress induced eNOS activation [33] . Our data also hint to a possible crosstalk between the β-adrenoreceptor and eNOS upstream of cAMP since the endotheliumdependence was much more pronounced for isoproterenol than for forskolin. The mechanism of such a cAMPindependent crosstalk is unclear. Maybe a hitherto unknown NOS-interacting protein could mediate the effect in analogy to the described eNOS binding protein hsp90 which serves as a scaffold protein facilitating the phosphorylation and activation of eNOS by PKB [34, 35] . Results obtained with cardiac myocytes suggest a colocalization of eNOS and the β-adrenoreceptor in caveolae which might be important for the crosstalk between both pathways as well [36, 37] .
The good correlation observed in our study between VASP phosphorylation and relaxation of the vascular smooth muscle cell layer strengthens the concept, that VASP is an important indicator of cGK I-induced relaxation of smooth muscle cells. Whether VASP phosphorylation actually mediates some aspects of cGK-I induced vasorelexation is not clear. Data from VASP knock-out mice confirmed the originally proposed role for VASP in platelet inhibition but did not reveal a role in NO/cGMP-induced vasorelaxation [38, 39] . However, a complete analysis of VASP deficient mice with respect to the vascular function under physiological and pathophysiological conditions is still lacking. Also, a large number of VASP-related proteins has been described that could substitute for VASP function in knock-out animals [4] . The most likely candidate is the VASP-related protein Mena, which shows conservation of both Ser 157 and Ser 239 phosphorylation sites and can be phosphorylated by cAK and cGK [22, 40] .
In order to compare data as different as vascular tone in an organ bath with protein phosphorylation it is very important to be able to perform both studies in the same tissue sample. Here, we established a method using small vessel pieces directly from the organ bath and analyzing the content of four different antigens and their phosphorylation in parallel in one lane of a Western blot. By this method we could study the activity of cyclic nucleotide regulated signalling pathways in the intact vessel wall with and without endothelium. It should be possible to monitor the activity of even more parameters of complex signal transduction pathways. However, this may require additional developments such as protein chips in order to increase the amount of detectable signals at a given time.
Our results clearly corroborate the concept that VASP phosphorylation can be used as a biochemical marker of the activity of cyclic nucleotide mediated vasodilatory pathways in the vessel wall. However, so far only VASP phosphorylation at Ser 239 has been studied extensively [14] [15] [16] [17] [18] [19] . Our present data demonstrate that VASP Ser 157 phosphorylation is also a well-suited marker with somewhat different specificity which adds to the biochemical analysis of vasorelaxation. After receptor-mediated activation of endothelial nitric oxide synthase (eNOS) by acetylcholine and after direct activation of soluble guanylyl cyclase with the NO-donor SNP both Ser 239 and Ser 157 of VASP were phosphorylated in parallel. Furthermore, the established endothelium-dependent and -independent vasorelaxant effects of acetylcholine and SNP, respectively, were clearly reflected by their effects on VASP phosphorylation. The cAMP-elevating vasodilators induced a differential phosphorylation of both VASP sites. Ser 239 was phosphorylated strongly after application of forskolin. This data seems to contradict the previously shown specificity of cGMP/cGK I towards the Ser 239 site [20, 22] . However we suggest that forskolin-induced phosphorylation of Ser 239 is a consequence of its endothelium-dependent activity. In the presence of endothelium forskolin might be able to activate the NO-pathway leading to increased activity of In the same samples VASP phosphorylation was detected as described in the legend to 
